Alternatively, treatment with dopamine agonists, such as cabergoline, is an option, though it has been shown to be less effective than somatostatin analogs; the best results with dopamine agonists are observed in “mixed” TSHomas that also secrete prolactin [23,24,25,26]. The gene discussed is PRL; the disease is TSH-secreting pituitary adenoma.